Capital International Investors Insmed Inc Transaction History
Capital International Investors
- $557 Billion
- Q2 2025
A detailed history of Capital International Investors transactions in Insmed Inc stock. As of the latest transaction made, Capital International Investors holds 7,478,859 shares of INSM stock, worth $912 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
7,478,859
Previous 7,198,485
3.89%
Holding current value
$912 Million
Previous $549 Million
37.06%
% of portfolio
0.14%
Previous 0.11%
Shares
6 transactions
Others Institutions Holding INSM
# of Institutions
578Shares Held
203MCall Options Held
2.84MPut Options Held
3.26M-
Darwin Global Management, Ltd. St. Helier, Y919.3MShares$2.36 Billion82.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$2.15 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.74 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$1.37 Billion0.13% of portfolio
-
Baker Bros. Advisors LP New York, NY7.71MShares$941 Million7.87% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $16.5B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...